Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion type Assertion NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_head.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion description "[Epidermal growth factor receptor (EGFR) transmembrane glycoprotein has been demonstrated to be overexpressed in pancreatic cancer, and it correlates with more advanced disease, poor survival, and the presence of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_provenance.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion evidence source_evidence_literature NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_provenance.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion SIO_000772 23560505 NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_provenance.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion wasDerivedFrom befree-20140225 NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_provenance.
- NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_assertion wasGeneratedBy ECO_0000203 NP430372.RAqm9N3Xg_3vCqkxXUqwIPvPM-dUF7SQG6Q6w9D8ZNO1Y130_provenance.